SE452007B - Amidinosubstituerade ureaforeningar och en farmaceutisk komposition for behandling av gastrointestinala eller kardiovaskulera rubbningar - Google Patents

Amidinosubstituerade ureaforeningar och en farmaceutisk komposition for behandling av gastrointestinala eller kardiovaskulera rubbningar

Info

Publication number
SE452007B
SE452007B SE8302283A SE8302283A SE452007B SE 452007 B SE452007 B SE 452007B SE 8302283 A SE8302283 A SE 8302283A SE 8302283 A SE8302283 A SE 8302283A SE 452007 B SE452007 B SE 452007B
Authority
SE
Sweden
Prior art keywords
guanidine
phenyl
acid addition
addition salts
pyridylamidino
Prior art date
Application number
SE8302283A
Other languages
English (en)
Swedish (sv)
Other versions
SE8302283D0 (sv
SE8302283L (en
Inventor
W L Studt
H K Zimmermann
S A Dodson
Original Assignee
Rorer Int Overseas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rorer Int Overseas filed Critical Rorer Int Overseas
Publication of SE8302283D0 publication Critical patent/SE8302283D0/xx
Publication of SE8302283L publication Critical patent/SE8302283L/xx
Publication of SE452007B publication Critical patent/SE452007B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8302283A 1981-08-24 1983-04-22 Amidinosubstituerade ureaforeningar och en farmaceutisk komposition for behandling av gastrointestinala eller kardiovaskulera rubbningar SE452007B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1981/001146 WO1983000627A1 (fr) 1981-08-24 1981-08-24 Urees heterocycliques a substitution amidino et leurs utilisations pharmaceutiques

Publications (3)

Publication Number Publication Date
SE8302283D0 SE8302283D0 (sv) 1983-04-22
SE8302283L SE8302283L (en) 1983-04-22
SE452007B true SE452007B (sv) 1987-11-09

Family

ID=22161395

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8302283A SE452007B (sv) 1981-08-24 1983-04-22 Amidinosubstituerade ureaforeningar och en farmaceutisk komposition for behandling av gastrointestinala eller kardiovaskulera rubbningar

Country Status (12)

Country Link
US (1) US4707478A (fr)
EP (1) EP0086775A4 (fr)
JP (1) JPS58501468A (fr)
AU (1) AU543834B2 (fr)
CA (1) CA1210394A (fr)
CH (1) CH656125A5 (fr)
DE (1) DE3152942T1 (fr)
DK (1) DK181583D0 (fr)
GB (1) GB2115419B (fr)
NL (1) NL8120313A (fr)
SE (1) SE452007B (fr)
WO (1) WO1983000627A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306696B1 (fr) * 1987-08-04 1994-02-16 Ciba-Geigy Ag Guanidines substituées
CA2116621C (fr) * 1993-03-03 2001-07-24 Rene C. Gaudreault Agents anticancereux
US5750547A (en) * 1995-01-06 1998-05-12 Universite Laval Certain carbanate anti-cancer agents
AUPN193095A0 (en) * 1995-03-24 1995-04-27 Polychip Pharmaceuticals Pty Ltd Potassium ion channel blockers
CN1738797A (zh) 2002-11-19 2006-02-22 阿基里昂药品公司 取代的芳基硫脲和相关的化合物,病毒复制的抑制剂
TW200600492A (en) * 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
CN114292225B (zh) * 2022-01-10 2023-07-11 万华化学集团股份有限公司 一种季铵型强碱性阴离子交换树脂及其催化制备甲基丙烯酸缩水甘油酯的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1194835A (en) * 1966-07-07 1970-06-10 Wellcome Found Novel 1-Amidino-3-Phenyl-Urea Derivatives, the preparation thereof and Compositions containing the same
US3798269A (en) * 1968-08-05 1974-03-19 R Cutler Amidinoureas and amidinothioureas
US3984467A (en) * 1969-03-03 1976-10-05 Sterling Drug Inc. Anthelmintic 1-(substituted phenyl)-3-alkanimidoyl ureas
US3933794A (en) * 1971-08-04 1976-01-20 The Upjohn Company 2-(2-Alkynylamino)-3H-1,4-benzodiazepines
US4220658A (en) * 1972-09-22 1980-09-02 William H. Rorer, Inc. Treatment of hypertension with amidinoureas
US4025652A (en) * 1975-03-31 1977-05-24 William H. Rorer, Inc. Amidinoureas
US4060635A (en) * 1975-03-31 1977-11-29 William H. Rorer, Inc. Amidinoureas for treating diarrhea
US4009163A (en) * 1973-08-24 1977-02-22 Sterling Drug Inc. Amidinoureas and amidinothioureas
US4163022A (en) * 1975-02-03 1979-07-31 Cooper Laboratories, Inc. Carbamylguanidine antimicrobial compounds
US4088785A (en) * 1976-03-25 1978-05-09 William H. Rorer, Inc. Amidinoureas for the treatment of cardinascular disorders
US4169155A (en) * 1976-03-30 1979-09-25 William H. Rorer, Inc. Method for treatment of gastrointestinal secretory and ulcerogenic disease conditions or symptoms in mammals
US4058557A (en) * 1976-03-30 1977-11-15 William H. Rorer, Inc. Amidinoureas
US4178387A (en) * 1976-03-30 1979-12-11 William H. Rorer, Inc. Method for the treatment of arrhythmia
JPS53108970A (en) * 1977-03-07 1978-09-22 Yamanouchi Pharmaceut Co Ltd Novel guanidine derivative and its preparation
US4166860A (en) * 1977-10-11 1979-09-04 William H. Rorer, Inc. Imidazole amidinoureas for stimulating H2 -receptors
US4304786A (en) * 1978-09-14 1981-12-08 William H. Rorer, Inc. Amidinoureas
US4225315A (en) * 1978-11-13 1980-09-30 William H. Rorer, Inc. Triazinones from amidinoureas
DE2853220A1 (de) * 1978-12-09 1980-07-03 Hoechst Ag Neue amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
US4340609A (en) * 1980-01-02 1982-07-20 William H. Rorer, Inc. Amidinourea derivative veterinary compositions for suppression of parasitemia
AU7535681A (en) * 1981-08-24 1983-03-08 Rorer International (Overseas) Inc. Treatment of infections

Also Published As

Publication number Publication date
GB8310965D0 (en) 1983-05-25
US4707478A (en) 1987-11-17
EP0086775A1 (fr) 1983-08-31
EP0086775A4 (fr) 1984-09-05
GB2115419B (en) 1985-10-02
SE8302283D0 (sv) 1983-04-22
JPS58501468A (ja) 1983-09-01
NL8120313A (nl) 1983-07-01
DK181583A (da) 1983-04-25
CH656125A5 (en) 1986-06-13
DK181583D0 (da) 1983-04-25
DE3152942T1 (de) 1983-12-15
CA1210394A (fr) 1986-08-26
GB2115419A (en) 1983-09-07
WO1983000627A1 (fr) 1983-03-03
AU7539481A (en) 1983-03-08
AU543834B2 (en) 1985-05-02
SE8302283L (en) 1983-04-22

Similar Documents

Publication Publication Date Title
DE68914793T2 (de) Chinazolinon-Derivate.
DE2656374C2 (fr)
US3966725A (en) 1-(4-Phenoxy-phenyl)-1,3,5-triazines
US3933814A (en) 1-(4-Phenoxyphenyl)-1,3,5-triazines
DE2421548A1 (de) Amine und ihre salze, verfahren zu ihrer herstellung und arzneimittel
IL28189A (en) Biologically active 1-amidino-3-(substituted phenyl) ureas
AU2035183A (en) Acyl guanidines
SE452007B (sv) Amidinosubstituerade ureaforeningar och en farmaceutisk komposition for behandling av gastrointestinala eller kardiovaskulera rubbningar
US3956302A (en) Substituted pyrimidines
CH645354A5 (de) Chinolyl-guanidine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mischungen.
DE2233458A1 (de) Neue chinolinderivate
US3211610A (en) Benzoic acid ester derivatives for treating coccidiosis and method of using same
US4076824A (en) Anthelmintic oxadiazolinone derivatives
EP0013817B1 (fr) 3-Dérivés d'urée thiénylique d'imidazole-1-ylidène-2, procédés pour leur préparation et leurs compositions pharmaceutiques
US2953578A (en) Sulfonyl urea compounds and a process of making same
EP0227026B1 (fr) Dérivés de la pyrazine, procédé pour leur préparation et compositions pharmaceutiques les contenant
EP0072954B1 (fr) Isoindolin-2-yl-amino-imidazolines et isoindolin-2-yl guanidines, procédé pour leur préparation et leur utilisation comme médicament
US3932617A (en) Interferon induction
US3384757A (en) Benzene sulfonyl ureas and process for their preparation
US3654296A (en) 2-chlorobenzothiazolecarboxamides
US3471508A (en) 5-aryl (or heteroaromatic) benzazoles
AT375656B (de) Verfahren zur herstellung von neuen 3-amino-5(4-pyridyl)-1,2,4-triazol-basen und ihren salzen
US4064243A (en) Heterocyclic-substituted 1,3,5-oxadiazin-2-one compounds useful for combatting coccidiosis
US3456058A (en) Aralkoxyguanidines,aryloxyalkoxyguanidines and salts thereof in anorectic methods and compositions
US3717623A (en) Sulfanilyl phenyl urea complexes useful against marek's disease

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8302283-0

Effective date: 19890911

Format of ref document f/p: F